SOURCE: Equity Markets Inc

October 26, 2011 09:00 ET

What's Ahead: Today's Economic Outlook -- Equity Research on HeartWare International Inc and St. Jude Medical, Inc.

MACAU--(Marketwire - Oct 26, 2011) - Today, www.EquityMarketsInc.com announced its research report highlighting HeartWare International Inc (NASDAQ: HTWR) and St. Jude Medical, Inc. (NYSE: STJ). Full content and research is available at www.EquityMarketsInc.com/research.php?id=HTWR+STJ.

Short-term outlooks within US and global economies continue to adjust downward, as US Treasury yields touched their lowest levels in over 65 years. International Monetary Fund downgraded estimates for US growth by 1.0% this year, down from 2.5%. 'Significant downside risks' to the US economy were confirmed by the Federal Reserve pressured by 'strains in global financial markets.'

As the US dollar trades above an eight-month high against the Euro, it highlights a deepening of the Eurozone sovereign debt crisis -- furthered by continued policy inaction from European governments. We expect continued volatility until economic data stabilizes and we see decisive policy action to deal with the Eurozone debt crisis.

Our members are preparing for a turn in tides. Currently, the Credit Suisse Risk Appetite Indicator is at a 30-year low. For the past three occurrences, this level has acted as a leading indicator of large stock market rallies 18 months following.

Equity Markets has reviewed HeartWare International Inc for its current position within the healthcare industry. HeartWare International, Inc. (HeartWare) develops and manufactures small implantable heart pumps, or ventricular assist devices, for the treatment of advanced heart failure. The full research report on HeartWare International Inc (NASDAQ: HTWR) is available here: www.EquityMarketsInc.com/research.php?id=HTWR.

Equity Markets has reviewed St. Jude Medical, Inc. for its development within the healthcare industry. St. Jude Medical, Inc. (St. Jude) develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiology and cardiac surgery and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The full research report on St. Jude Medical, Inc. (NYSE: STJ) is available here: www.EquityMarketsInc.com/research.php?id=STJ.

About Equity Markets
Our mission at Equity Markets is to be the best source of content and research, while educating, enlightening and informing investors. Equity Markets combines street smart analysts and professional market researchers to provide investors with detailed company profiles and market coverage.

Contact Information